HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Atrazine-induced aromatase expression is SF-1 dependent: implications for endocrine disruption in wildlife and reproductive cancers in humans.

AbstractBACKGROUND:
Atrazine is a potent endocrine disruptor that increases aromatase expression in some human cancer cell lines. The mechanism involves the inhibition of phosphodiesterase and subsequent elevation of cAMP.
METHODS:
We compared steroidogenic factor 1 (SF-1) expression in atrazine responsive and non-responsive cell lines and transfected SF-1 into nonresponsive cell lines to assess SF-1's role in atrazine-induced aromatase. We used a luciferase reporter driven by the SF-1-dependent aromatase promoter (ArPII) to examine activation of this promoter by atrazine and the related simazine. We mutated the SF-1 binding site to confirm the role of SF-1. We also examined effects of 55 other chemicals. Finally, we examined the ability of atrazine and simazine to bind to SF-1 and enhance SF-1 binding to ArPII.
RESULTS:
Atrazine-responsive adrenal carcinoma cells (H295R) expressed 54 times more SF-1 than nonresponsive ovarian granulosa KGN cells. Exogenous SF-1 conveyed atrazine-responsiveness to otherwise nonresponsive KGN and NIH/3T3 cells. Atrazine induced binding of SF-1 to chromatin and mutation of the SF-1 binding site in ArPII eliminated SF-1 binding and atrazine-responsiveness in H295R cells. Out of 55 chemicals examined, only atrazine, simazine, and benzopyrene induced luciferase via ArPII. Atrazine bound directly to SF-1, showing that atrazine is a ligand for this "orphan" receptor.
CONCLUSION:
The current findings are consistent with atrazine's endocrine-disrupting effects in fish, amphibians, and reptiles; the induction of mammary and prostate cancer in laboratory rodents; and correlations between atrazine and similar reproductive cancers in humans. This study highlights the importance of atrazine as a risk factor in endocrine disruption in wildlife and reproductive cancers in laboratory rodents and humans.
AuthorsWuQiang Fan, Toshihiko Yanase, Hidetaka Morinaga, Shigeki Gondo, Taijiro Okabe, Masatoshi Nomura, Tomoko Komatsu, Ken-Ichirou Morohashi, Tyrone B Hayes, Ryoichi Takayanagi, Hajime Nawata
JournalEnvironmental health perspectives (Environ Health Perspect) Vol. 115 Issue 5 Pg. 720-7 (May 2007) ISSN: 0091-6765 [Print] United States
PMID17520059 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA Primers
  • Endocrine Disruptors
  • Environmental Pollutants
  • Ligands
  • Steroidogenic Factor 1
  • Luciferases
  • Aromatase
  • Atrazine
  • Simazine
Topics
  • Analysis of Variance
  • Animals
  • Aromatase (genetics, metabolism)
  • Atrazine (toxicity)
  • Binding Sites (genetics)
  • Blotting, Western
  • Cell Line, Tumor
  • DNA Primers
  • Endocrine Disruptors (toxicity)
  • Environmental Pollutants (toxicity)
  • Gene Expression Regulation, Enzymologic (drug effects)
  • Humans
  • Ligands
  • Luciferases (metabolism)
  • Mice
  • Mutation (genetics)
  • Promoter Regions, Genetic (genetics)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Simazine (metabolism)
  • Steroidogenic Factor 1 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: